The CU Healthcare Innovation Fund is an early-stage venture capital firm that invests in healthcare sectors such as life sciences and digital health within the United States. Its strategy focuses on opportunities with intellectual property originating from the CU Anschutz Medical Campus or those with an engagement or partnership with the campus or its affiliated health systems. The fund prioritizes technologies that address unmet medical needs, possess strong intellectual property, and have a clear path to commercialization, with a particular emphasis on data-driven precision medicine, digital health, and novel therapeutics.
67% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-b (67% of deals). Average disclosed round size is $15.4M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$100M
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Carta Healthcare | Series B | $18.3M | May 2025 |
 Eon | Growth | $16M | Apr 2022 |
 Babyscripts | Series B | $12M | Sep 2021 |
Top Co-Investors
Last updated: 10 April 2026